Medtronic Snaps Up Aneurysm Mesh Tech for $150 Million
Monday, August 31, 2015
Medtronic said Monday that it will spend $150 million in cash to purchase Menlo Park, CA–based Medina Medical, which has been commercializing cutting edge treatments for vascular abnormalities of the brain including cerebral aneurysms.
Medtronic had already bought an ownership stake in the company.
This is Medtronic’s ninth company purchase or major investment since the January closing of its massive $48 billion acquisition of Covidien, which has it rivaling Johnson & Johnson as the largest medical device company in the world.